Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in β-adrenoceptor density and systolic function in rat cardiac myocytes

被引:27
作者
Flesch, M
Ettelbrück, S
Rosenkranz, S
Maack, C
Cremers, B
Schlüter, KD
Zolk, O
Bohm, M
机构
[1] Univ Cologne, Innere Med Klin 3, D-50924 Cologne, Germany
[2] Univ Homburg, Kliniken Saarlandes, D-66421 Homburg, Germany
[3] Univ Giessen, Inst Physiol, D-35392 Giessen, Germany
[4] Univ Erlangen Nurnberg, Inst Expt & Klin Pharmakol & Toxikol, D-91054 Erlangen, Germany
关键词
adrenergic (ant)agonists; heart failure; myocytes; receptors;
D O I
10.1016/S0008-6363(00)00277-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: beta -Blockers improve cardiac function and survival in heart failure patients. The underlying mechanisms are not completely elucidated. Differences between agents might be important for the development of more specific therapeutical approaches. This study investigated whether metoprolol or carvedilol alter beta -adrenergic signaling differently. Methods: beta -Adrenoceptor density and systolic function were determined in rat adult ventricular cardiac myocytes. Results: 12 h isoprenaline-treatment (Iso, 1 mu mol/l) reduced beta -adrenoceptor density by 33% (P<0.01). The effect was abolished by incubation with isoprenaline plus metoprolol (3 <mu>mol/l), but was more pronounced after coincubation with carvedilol (0.003 mu mol/l, P<0.05 Carv vs. Iso). Metoprolol alone had no effect on P-adrenoceptor density, but carvedilol induced a decrease in receptor density even in absence of isoprenaline (P<0.05 Carv vs. ctr.). The isoprenaline (0.0003-10 mu mol/l) induced concentration-dependent increase in myocyte shortening was blunted after 12 h preincubation with Iso (1 mu mol/l, P<0.001). This reduction was abolished or partly prevented by coincubation with metoprolol or carvedilol, respectively. Carvedilol decreased the number of receptors which had to be occupied by isoprenaline in order to obtain 50% and 90% increase in myocyte cell shortening. Comparison of guanine nucleotide-dependent binding characteristics of isoprenaline, carvedilol and metoprolol revealed <beta>-receptor agonist like binding characteristics for carvedilol, but antagonist like binding characteristics for metoprolol. Conclusion: Metoprolol but not carvedilol prevents isoprenaline-induced downregulation of myocyte beta -adrenoceptors. The difference might be due to specific binding propel-ties of the beta -blockers. Restoration of isoprenaline responsiveness by carvedilol might be due to improved coupling of beta -receptors to postreceptor effects. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:371 / 380
页数:10
相关论文
共 46 条
[1]   IMPROVED EXERCISE HEMODYNAMIC STATUS IN DILATED CARDIOMYOPATHY AFTER BETA-ADRENERGIC-BLOCKADE TREATMENT [J].
ANDERSSON, B ;
HAMM, C ;
PERSSON, S ;
WIKSTROM, G ;
SINAGRA, G ;
HJALMARSON, A ;
WAAGSTEIN, F .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (06) :1397-1404
[2]   ALPHA(1)-ADRENOCEPTOR-MEDIATED INHIBITION OF CELLULAR CAMP ACCUMULATION IN NEONATAL RAT VENTRICULAR MYOCYTES [J].
BARRETT, S ;
HONBO, N ;
KARLINER, JS .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 347 (04) :384-393
[3]  
BENOVIC JL, 1988, J BIOL CHEM, V263, P3893
[4]  
BOGOYEVITCH MA, 1996, BIOCHEM J, V15, P115
[5]   beta-Adrenergic signal transduction in the failing and hypertrophied myocardium [J].
Bohm, M ;
Flesch, M ;
Schnabel, P .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (11-12) :842-848
[6]   β-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy [J].
Böhm, M ;
Ettelbrück, S ;
Flesch, M ;
van Gilst, WH ;
Knorr, A ;
Maack, C ;
Pinto, YM ;
Paul, M ;
Teisman, ACH ;
Zolk, O .
CARDIOVASCULAR RESEARCH, 1998, 40 (01) :146-155
[7]   RADIOIMMUNOCHEMICAL QUANTIFICATION OF GI-ALPHA IN RIGHT-AND-LEFT-VENTRICLES FROM PATIENTS WITH ISCHEMIC AND DILATED CARDIOMYOPATHY AND PREDOMINANT LEFT-VENTRICULAR FAILURE [J].
BOHM, M ;
ESCHENHAGEN, T ;
GIERSCHIK, P ;
LARISCH, K ;
LENSCHE, H ;
MENDE, U ;
SCHMITZ, W ;
SCHNABEL, P ;
SCHOLZ, H ;
STEINFATH, M ;
ERDMANN, E .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1994, 26 (02) :133-149
[8]   DOSE-RESPONSE OF CHRONIC BETA-BLOCKER TREATMENT IN HEART-FAILURE FROM EITHER IDIOPATHIC DILATED OR ISCHEMIC CARDIOMYOPATHY [J].
BRISTOW, MR ;
OCONNELL, JB ;
GILBERT, EM ;
FRENCH, WJ ;
LEATHERMAN, G ;
KANTROWITZ, NE ;
ORIE, J ;
SMUCKER, ML ;
MARSHALL, G ;
KELLY, P ;
DEITCHMAN, D ;
ANDERSON, JL .
CIRCULATION, 1994, 89 (04) :1632-1642
[9]  
BRISTOW MR, 1992, CIRCULATION, V86, P646
[10]   DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211